Jan 10 (Reuters) - Integra Lifesciences Holdings Corp
IART.O :
* INTEGRA LIFESCIENCES REPORTS SELECT PRELIMINARY FOURTH
QUARTER
AND FULL-YEAR 2022 FINANCIALS
* INTEGRA LIFESCIENCES HOLDINGS CORP - Q4 2022 REVENUE IS
EXPECTED
TO BE IN A RANGE OF $397 MILLION TO $398 MILLION
* INTEGRA LIFESCIENCES HOLDINGS CORP - Q4 2022 ADJUSTED
EARNINGS
PER DILUTED SHARE IS EXPECTED TO BE ABOVE HIGH END OF COMPANY'S
OCTOBER GUIDANCE RANGE
* INTEGRA LIFESCIENCES HOLDINGS CORP - REITERATING ITS PLANS
TO
INITIATE A $150 MILLION SHARE REPURCHASE IN 2023
Source text for Eikon: ID:nGNX2Wcldq
Further company coverage: IART.O
((Reuters.Briefs@thomsonreuters.com;))